US EditionRevelation Biosciences Rockets Premarket After $4M Boost – Own Snap
Summary by ownsnap.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Revelation Biosciences Rockets Premarket After $4M Boost – Own Snap
Revelation Biosciences (REVB), the San Diego-based biotech firm focused on boosting immune responses to fight disease, is just facing over 45% gain in premarket session. This growth is directly related to its $4 million public offering to inject funds for supporting R and D efforts. That could be a real game-changer for their work on infection prevention and kidney health. Now for the numbers. As of early this morning REVB stock is trading at $…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
